Danish pharmaceutical giant Novo Nordisk has made inroads into the market in Pakistan and expects a rosy future thanks to a growth rate of around 30 percent per year.

Novo Nordisk has almost tripled its employee numbers in Pakistan in a few short years from 53 in 2010 to 153 now, and Lars Rebien Sørensen, the head of Novo Nordisk, sees great potential.

Novo Nordisk has had a subsidiary operating in Pakistan since 2005, but had already launched insulin products in the Pakistani market back in 1989.

http://cphpost.dk/